Current guidelines for HCC screening include every six months abdominal ultrasound (US), with or without serum alpha-fetoprotein (α-FP), in patients with cirrhosis and subgroups with chronic hepatitis B virus (CHB) infection [1,9,10,11]. The gene discussed is AFP; the disease is hepatocellular carcinoma.